Mga Industriya
Showing 31–40 ng mga 44 results
-
Bladder Cancer Market in China
Ayon sa StrategyHelix, the bladder cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.1% sa panahon ng pagsusuri ng 2021 sa 2027.
-
Pancreatic Cancer Market in China
According to a statistic by StrategyHelix, the pancreatic cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.3% sa panahon ng pagtataya (2021-2027).
-
Lymphoma Market in China
Ayon sa StrategyHelix, the lymphoma market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 2.3% sa susunod na limang taon.
-
Urothelial Cancer Market in China
According to a statistic by StrategyHelix, the urothelial cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.2% mula sa 2021 sa pamamagitan ng 2027.
-
Gastric Cancer Market in China
The gastric cancer market in China was estimated at 470 libong units sa 2020 and is anticipated to reach 579 thousand units by 2027, umuusad sa isang CAGR ng 3% throughout the forecast period, ayon sa StrategyHelix.
-
Breast Cancer Market in China
Ayon sa StrategyHelix, the breast cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.2% mula sa 2021 sa pamamagitan ng 2027.
-
Non-small-cell Lung Carcinoma (NSCLC) Market in China
At 3% CAGR, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 thousand units by 2027, ayon sa data at analytics company na StrategyHelix.
-
Nasopharyngeal Cancer Market in China
According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.2% sa susunod na limang taon.
-
Head and Neck Cancer Market in China
The head and neck cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.7% mula sa 2021 sa pamamagitan ng 2027, ayon sa data at analytics company na StrategyHelix.
-
Oncology Drug Market in China
The oncology drug market in China is poised to grow at a CAGR of around 13.3% sa panahon ng pagsusuri ng 2021 sa 2027, ayon sa data at analytics company na StrategyHelix.